Overview

Pharmacokinetic Parameters of Stiripentol in Renal Impaired Patients and Matching Controls With Normal Renal Function

Status:
Not yet recruiting

Trial end date:
2024-03-14

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether the pharmacokinetics (PK) of stiripentol and of its relevant metabolites would be altered in subjects with renal impairment compared with normal controls in order to assess the need of dose adjustment in the renal impaired population. This study will include subjects with mild, moderate and severe renal impairment.

Phase:

Phase 1

Details

Lead Sponsor:

Biocodex

Treatments:

Stiripentol